Bio-Techne Quarterly Income Statements Chart
Quarterly
|
Annual
Bio-Techne Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2016-09-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | |||||||||||||||||||||||||||||||||||||||||||||||||||
| net sales | 316,964,000 | 316,181,000 | 297,031,000 | 289,458,000 | 306,099,000 | 303,428,000 | 272,598,000 | 276,935,000 | 301,320,000 | 294,146,000 | 271,581,000 | 269,655,000 | 288,228,000 | 290,376,000 | 269,276,000 | 257,719,000 | 259,028,000 | 243,552,000 | 224,253,000 | 204,199,000 | 175,834,000 | 194,680,000 | 184,934,000 | 183,243,000 | 191,665,000 | 184,861,000 | 174,510,000 | 162,970,000 | 180,254,000 | 163,973,000 | 154,153,000 | 130,581,000 | 130,973,000 | 120,907,000 | 112,381,000 | 117,663,000 | 114,158,000 | 108,477,000 | 92,523,000 | 95,555,000 | 84,017,000 | 85,668,000 | 79,475,000 | 80,992,000 | 75,083,000 | 75,025,000 | 78,681,000 | 83,621,000 | 74,662,000 | 77,596,000 | |
| cost of sales | 118,152,000 | 101,625,000 | 103,145,000 | 106,441,000 | 102,751,000 | 98,829,000 | 96,011,000 | 91,744,000 | 96,622,000 | 91,984,000 | 88,221,000 | 90,060,000 | 87,878,000 | 88,918,000 | 85,585,000 | 86,722,000 | 83,084,000 | 75,278,000 | 73,353,000 | 66,468,000 | 62,520,000 | 64,617,000 | 63,531,000 | 64,829,000 | 63,405,000 | 60,251,000 | 61,492,000 | 55,367,000 | 58,073,000 | 53,712,000 | 52,319,000 | 46,111,000 | 40,984,000 | 39,320,000 | 36,990,000 | 38,575,000 | 34,778,000 | 35,411,000 | 28,930,000 | 27,444,000 | 25,424,000 | 24,554,000 | 20,358,000 | 19,845,000 | 19,820,000 | 19,442,000 | 19,817,000 | 20,238,000 | 19,492,000 | 19,209,000 | |
| gross margin | 198,812,000 | 214,556,000 | 193,886,000 | 183,017,000 | 203,348,000 | 204,599,000 | 176,587,000 | 185,191,000 | 204,698,000 | 202,162,000 | 183,360,000 | 179,595,000 | 200,350,000 | 201,458,000 | 183,691,000 | 170,997,000 | 175,944,000 | 168,274,000 | 150,900,000 | 137,731,000 | 113,314,000 | 130,063,000 | 121,403,000 | 118,414,000 | 128,260,000 | 124,610,000 | 113,018,000 | 107,603,000 | 122,181,000 | 110,261,000 | 101,834,000 | 84,470,000 | 89,989,000 | 81,587,000 | 75,391,000 | 79,088,000 | 79,380,000 | 73,066,000 | 63,593,000 | 68,111,000 | 58,593,000 | 61,114,000 | 59,117,000 | 61,147,000 | 55,263,000 | 55,583,000 | 58,864,000 | 63,383,000 | 55,170,000 | 58,387,000 | |
| yoy | -2.23% | 4.87% | 9.80% | -1.17% | -0.66% | 1.21% | -3.69% | 3.12% | 2.17% | 0.35% | -0.18% | 5.03% | 13.87% | 19.72% | 21.73% | 24.15% | 55.27% | 29.38% | 24.30% | 16.31% | -11.65% | 4.38% | 7.42% | 10.05% | 4.98% | 13.01% | 10.98% | 27.39% | 35.77% | 35.15% | 35.07% | 6.81% | 13.36% | 11.66% | 18.55% | 16.12% | 35.48% | 19.56% | 7.57% | 11.39% | 6.03% | 9.95% | 0.43% | -3.53% | 0.17% | -4.80% | |||||
| qoq | -7.34% | 10.66% | 5.94% | -10.00% | -0.61% | 15.86% | -4.65% | -9.53% | 1.25% | 10.25% | 2.10% | -10.36% | -0.55% | 9.67% | 7.42% | -2.81% | 4.56% | 11.51% | 9.56% | 21.55% | -12.88% | 7.13% | 2.52% | -7.68% | 2.93% | 10.26% | 5.03% | -11.93% | 10.81% | 8.28% | 20.56% | -6.13% | 10.30% | 8.22% | -4.67% | -0.37% | 8.64% | 14.90% | -6.63% | 16.24% | -4.13% | 3.38% | -3.32% | 10.65% | -0.58% | -5.57% | -7.13% | 14.89% | -5.51% | ||
| gross margin % | |||||||||||||||||||||||||||||||||||||||||||||||||||
| operating expenses: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| selling, general and administrative | 196,640,000 | 151,269,000 | 121,451,000 | 119,161,000 | 133,536,000 | 111,840,000 | 115,667,000 | 105,331,000 | 86,754,000 | 99,238,000 | 93,010,000 | 99,375,000 | 96,629,000 | 89,269,000 | 100,693,000 | 86,175,000 | 86,641,000 | 82,596,000 | 83,116,000 | 72,598,000 | 57,225,000 | 66,318,000 | 68,030,000 | 69,010,000 | 68,737,000 | 64,968,000 | 63,603,000 | 67,051,000 | 65,287,000 | 53,285,000 | 63,775,000 | 46,263,000 | 35,217,000 | 34,585,000 | 33,040,000 | 30,474,000 | 29,089,000 | 28,701,000 | 17,103,000 | 14,666,000 | 14,926,000 | 14,021,000 | 12,118,000 | 9,982,000 | 10,956,000 | 10,328,000 | 10,360,000 | 9,899,000 | 10,651,000 | 10,773,000 | |
| research and development | 26,032,000 | 24,579,000 | 25,016,000 | 23,869,000 | 23,989,000 | 25,761,000 | 22,916,000 | 23,998,000 | 23,419,000 | 22,713,000 | 22,459,000 | 23,903,000 | 23,148,000 | 21,742,000 | 20,650,000 | 21,600,000 | 20,721,000 | 17,052,000 | 16,789,000 | 16,041,000 | 16,779,000 | 15,954,000 | 16,381,000 | 16,077,000 | 16,259,000 | 15,552,000 | 15,812,000 | 14,789,000 | 13,979,000 | 13,892,000 | 13,911,000 | 12,765,000 | 11,245,000 | 10,977,000 | 11,322,000 | 10,813,000 | 10,865,000 | 9,149,000 | 7,644,000 | 7,676,000 | 7,923,000 | 7,702,000 | 7,183,000 | 7,219,000 | 7,403,000 | 7,452,000 | 7,286,000 | 7,122,000 | 6,837,000 | 6,667,000 | |
| total operating expenses | 222,672,000 | 175,848,000 | 146,467,000 | 143,030,000 | 157,525,000 | 137,601,000 | 138,583,000 | 129,329,000 | 110,173,000 | 121,951,000 | 115,469,000 | 123,278,000 | 119,777,000 | 111,011,000 | 121,343,000 | 107,775,000 | 107,362,000 | 99,648,000 | 99,905,000 | 88,639,000 | 74,004,000 | 82,272,000 | 84,411,000 | 85,087,000 | 84,996,000 | 80,520,000 | 79,415,000 | 81,840,000 | 79,266,000 | 67,177,000 | 77,686,000 | 59,028,000 | 46,462,000 | 45,562,000 | 44,362,000 | 41,287,000 | 39,954,000 | 37,850,000 | 24,747,000 | 22,342,000 | 22,849,000 | 21,723,000 | 19,301,000 | 17,201,000 | 18,359,000 | 17,780,000 | 17,646,000 | 17,021,000 | 17,488,000 | 17,440,000 | |
| operating income | -23,860,000 | 38,708,000 | 47,419,000 | 39,987,000 | 45,823,000 | 66,998,000 | 38,004,000 | 55,862,000 | 94,525,000 | 80,211,000 | 67,891,000 | 56,317,000 | 80,573,000 | 90,447,000 | 62,348,000 | 63,222,000 | 68,582,000 | 68,626,000 | 50,995,000 | 49,092,000 | 39,310,000 | 47,791,000 | 36,992,000 | 33,327,000 | 43,264,000 | 44,090,000 | 33,603,000 | 25,763,000 | 42,915,000 | 43,084,000 | 24,148,000 | 25,442,000 | 43,527,000 | 36,025,000 | 31,028,000 | 37,801,000 | 39,426,000 | 35,216,000 | 38,846,000 | 45,769,000 | 35,744,000 | 39,391,000 | 39,816,000 | 43,946,000 | 36,904,000 | 37,803,000 | 41,218,000 | 46,362,000 | 37,682,000 | 40,947,000 | |
| yoy | -152.07% | -42.23% | 24.77% | -28.42% | -51.52% | -16.47% | -44.02% | -0.81% | 17.32% | -11.32% | 8.89% | -10.92% | 17.48% | 31.80% | 22.26% | 28.78% | 74.46% | 43.60% | 37.85% | 47.30% | -9.14% | 8.39% | 10.09% | 29.36% | 0.81% | 2.33% | 39.15% | 1.26% | -1.41% | 19.59% | -22.17% | -32.69% | 10.40% | 2.30% | -20.13% | -17.41% | 10.30% | -10.60% | -2.44% | 4.15% | -3.14% | 4.20% | -3.40% | -5.21% | -2.06% | -7.68% | |||||
| qoq | -161.64% | -18.37% | 18.59% | -12.74% | -31.61% | 76.29% | -31.97% | -40.90% | 17.85% | 18.15% | 20.55% | -30.10% | -10.92% | 45.07% | -1.38% | -7.82% | -0.06% | 34.57% | 3.88% | 24.88% | -17.75% | 29.19% | 11.00% | -22.97% | -1.87% | 31.21% | 30.43% | -39.97% | -0.39% | 78.42% | -5.09% | -41.55% | 20.82% | 16.10% | -17.92% | -4.12% | 11.95% | -9.34% | -15.13% | 28.05% | -9.26% | -1.07% | -9.40% | 19.08% | -2.38% | -8.29% | -11.10% | 23.03% | -7.97% | ||
| operating margin % | |||||||||||||||||||||||||||||||||||||||||||||||||||
| other income | -1,198,250 | -434,000 | -4,543,000 | 184,000 | -4,208,750 | -5,914,000 | -4,617,000 | -6,304,000 | 11,481,000 | -15,000 | -1,462,000 | 47,399,000 | 1,579,250 | -21,675,000 | 23,831,000 | 4,161,000 | -6,913,000 | -23,272,000 | 5,373,000 | -9,753,000 | 24,210,750 | -970,000 | 113,334,000 | -15,521,000 | -3,556,500 | 5,787,000 | -11,836,000 | -8,177,000 | -5,895,250 | -18,102,000 | -2,417,000 | -1,314,000 | -1,037,000 | -651,000 | 818,000 | 1,674,500 | -667,000 | -618,000 | |||||||||||||
| earnings before income taxes | -22,859,000 | 38,274,000 | 42,876,000 | 40,171,000 | 41,661,000 | 61,084,000 | 33,387,000 | 49,558,000 | 88,316,000 | 80,196,000 | 66,429,000 | 103,716,000 | 79,052,000 | 68,772,000 | 86,179,000 | 67,383,000 | 7,113,000 | 45,354,000 | 56,368,000 | 39,339,000 | 61,525,000 | 46,821,000 | 150,326,000 | 17,806,000 | 22,786,000 | 49,877,000 | 21,767,000 | 17,586,000 | 56,270,000 | 24,982,000 | 21,731,000 | 24,128,000 | 42,490,000 | 35,374,000 | 31,847,000 | 38,242,000 | 38,759,000 | 34,598,000 | 39,451,000 | 46,069,000 | 36,218,000 | 39,654,000 | 40,764,000 | 44,466,000 | 37,446,000 | 37,986,000 | 40,617,000 | 43,205,000 | 37,873,000 | 40,500,000 | |
| income taxes | -5,181,000 | 15,686,000 | 7,986,000 | 6,571,000 | 1,073,000 | 12,025,000 | 5,922,000 | -1,435,000 | 12,832,000 | 9,978,000 | 16,424,000 | 13,982,000 | 17,137,000 | 8,628,000 | 14,120,000 | -1,598,000 | -7,531,000 | -48,000 | 10,224,000 | 5,944,000 | 2,680,000 | 10,389,000 | 30,704,000 | 3,408,000 | 183,000 | 7,845,000 | 12,199,000 | 9,523,000 | 9,139,000 | 11,913,000 | 14,469,000 | 10,691,000 | 12,627,000 | 14,428,000 | 11,163,000 | 12,226,000 | 12,353,000 | 11,348,000 | 12,082,000 | 12,318,000 | 13,376,000 | 11,449,000 | 12,060,000 | 12,979,000 | |||||||
| net earnings | -17,678,000 | 22,588,000 | 34,890,000 | 33,600,000 | 33,395,000 | 58,845,000 | 36,432,000 | 119,622,000 | 14,398,000 | 16,460,000 | 44,654,000 | 17,556,000 | 17,403,000 | 41,701,000 | 19,738,000 | 48,847,000 | 16,281,000 | 30,291,000 | 25,851,000 | 22,707,000 | 26,329,000 | 24,290,000 | 23,907,000 | 26,824,000 | 31,641,000 | 25,055,000 | 27,428,000 | 28,411,000 | 33,118,000 | 25,364,000 | 25,668,000 | 27,241,000 | 31,756,000 | 25,813,000 | 27,521,000 | ||||||||||||||||
| other comprehensive income: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| foreign currency translation income | 22,953,000 | 5,311,000 | -25,518,000 | 21,256,000 | -1,934,000 | -11,981,000 | 18,025,000 | ||||||||||||||||||||||||||||||||||||||||||||
| unrealized gains on derivative instruments - cash flow hedges, net of tax | -781,000 | -1,713,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| other comprehensive income | 22,172,000 | 3,598,000 | -25,563,000 | 18,229,000 | -3,009,000 | -11,646,000 | 14,355,000 | -11,952,000 | 7,487,000 | 1,574,000 | 16,685,000 | -16,643,000 | -20,151,000 | 4,328,000 | 4,808,000 | -6,964,000 | 6,821,000 | 146,000 | 18,987,000 | 14,057,000 | 6,258,000 | -25,105,000 | 13,275,000 | -8,106,000 | -3,887,000 | 3,378,000 | -12,379,000 | -1,136,000 | -28,952,000 | 40,956,000 | -7,058,000 | 6,480,000 | -24,953,000 | 2,088,000 | 11,029,000 | -17,145,000 | -1,479,000 | 6,044,000 | 4,368,000 | 1,716,000 | 2,587,000 | ||||||||||
| comprehensive income | 4,494,000 | 26,186,000 | 9,327,000 | 51,829,000 | 47,452,000 | 65,103,000 | 11,327,000 | 132,897,000 | 6,292,000 | 12,573,000 | 48,032,000 | 5,177,000 | 16,267,000 | 12,749,000 | 60,694,000 | 41,789,000 | 22,761,000 | 5,338,000 | 27,939,000 | -314,000 | 37,358,000 | 7,145,000 | 6,316,000 | 25,345,000 | 37,685,000 | 29,423,000 | -1,446,000 | 30,127,000 | 35,705,000 | 23,473,000 | 16,034,000 | ||||||||||||||||||||
| earnings per share: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| basic | -0.11 | 0.14 | 0.22 | 0.21 | 0.26 | 0.31 | 0.17 | 0.32 | 0.47 | 0.45 | 0.32 | 2.28 | 1.57 | 1.55 | 2.04 | 1.78 | 0.38 | 1.18 | 1.2 | 0.87 | 1.54 | 0.95 | 3.13 | 0.38 | 0.43 | 1.18 | 0.46 | 0.46 | 1.11 | 0.53 | 1.3 | 0.44 | 0.81 | 0.7 | 0.61 | 0.7 | 0.65 | 0.65 | 0.73 | 0.86 | 0.68 | 0.74 | 0.78 | 0.9 | 0.69 | 0.7 | 0.74 | 0.86 | 0.7 | 0.74 | |
| diluted | -0.11 | 0.14 | 0.22 | 0.21 | 0.26 | 0.31 | 0.17 | 0.31 | 0.46 | 0.43 | 0.31 | 2.21 | 1.51 | 1.48 | 1.94 | 1.69 | 0.36 | 1.12 | 1.15 | 0.83 | 1.49 | 0.92 | 3.02 | 0.37 | 0.42 | 1.15 | 0.45 | 0.45 | 1.09 | 0.52 | 1.29 | 0.43 | 0.81 | 0.69 | 0.61 | 0.7 | 0.65 | 0.64 | 0.73 | 0.85 | 0.68 | 0.74 | 0.77 | 0.9 | 0.69 | 0.7 | 0.74 | 0.86 | 0.7 | 0.74 | |
| weighted-average common shares outstanding: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| basic | 157,521 | 157,372 | 158,431 | 158,531 | 157,708 | 157,309 | 157,533 | 158,130 | 157,179 | 157,311 | 157,011 | 39,232 | 39,219 | 39,272 | 39,310 | 39,094 | 38,747 | 38,856 | 38,691 | 38,536 | 38,201 | 38,303 | 38,167 | 38,032 | 37,781 | 37,772 | 37,766 | 37,697 | 37,476 | 37,503 | 37,449 | 37,281 | 37,196 | 37,189 | 37,169 | 37,096 | 37,138 | 37,007 | 36,890 | 36,911 | 36,882 | 36,842 | 36,836 | 36,842 | 36,834 | 36,828 | 36,939 | 36,864 | 36,966 | 37,095 | |
| diluted | 159,717 | 158,944 | 160,626 | 161,115 | 160,774 | 160,496 | 160,060 | 161,940 | 161,855 | 161,615 | 161,750 | 40,543 | 41,029 | 40,969 | 41,207 | 41,158 | 40,483 | 40,676 | 40,257 | 40,025 | 39,401 | 39,435 | 39,550 | 39,253 | 38,892 | 38,861 | 38,748 | 38,813 | 38,055 | 38,142 | 37,926 | 37,473 | 37,299 | 37,301 | 37,315 | 37,231 | 37,269 | 37,148 | 37,005 | 37,053 | 37,015 | 36,928 | 36,900 | 36,908 | 36,900 | 36,895 | 37,006 | 36,930 | 37,028 | 37,170 | |
| unrealized gains on derivative instruments - cash flow hedges, net of tax amounts disclosed in note 8 | -45,000 | -3,027,000 | -1,075,000 | 335,000 | -3,670,000 | -350,000 | 2,491,000 | -1,708,000 | -685,000 | 4,695,000 | 2,517,000 | 7,179,000 | 2,884,000 | 1,682,000 | |||||||||||||||||||||||||||||||||||||
| net earnings, including noncontrolling interest | 40,588,000 | 49,059,000 | 27,465,000 | 50,993,000 | 75,484,000 | 70,218,000 | 50,005,000 | 89,734,000 | 61,915,000 | 60,144,000 | 72,059,000 | 68,981,000 | 14,644,000 | 45,402,000 | 46,144,000 | ||||||||||||||||||||||||||||||||||||
| net earnings attributable to noncontrolling interest | 179,000 | 391,000 | -595,000 | -8,114,000 | -634,000 | -316,000 | -380,000 | -130,000 | |||||||||||||||||||||||||||||||||||||||||||
| net earnings attributable to bio-techne | 40,588,000 | 49,059,000 | 27,465,000 | 50,993,000 | 75,484,000 | 70,218,000 | 50,005,000 | 89,555,000 | 61,524,000 | 60,739,000 | 80,173,000 | 69,615,000 | 14,960,000 | 45,782,000 | 46,274,000 | ||||||||||||||||||||||||||||||||||||
| foreign currency translation reclassified to earnings with eminence deconsolidation | 119,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| other comprehensive income attributable to noncontrolling interest | -33,000 | -96,000 | -1,000 | 66,000 | -39,000 | 89,000 | -69,000 | 83,000 | |||||||||||||||||||||||||||||||||||||||||||
| other comprehensive income attributable to bio-techne | -3,009,000 | -11,646,000 | 14,355,000 | -11,952,000 | 7,487,000 | 1,574,000 | 16,685,000 | -16,610,000 | -20,055,000 | 4,329,000 | 4,742,000 | -6,925,000 | 8,294,000 | 215,000 | 18,904,000 | ||||||||||||||||||||||||||||||||||||
| comprehensive income attributable to bio-techne | 37,579,000 | 37,413,000 | 41,820,000 | 39,041,000 | 82,971,000 | 71,792,000 | 66,690,000 | 72,945,000 | 41,469,000 | 65,068,000 | 84,915,000 | 62,690,000 | 21,692,000 | 45,997,000 | 65,178,000 | ||||||||||||||||||||||||||||||||||||
| earnings per share attributable to bio-techne: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| basic | -0.11 | 0.14 | 0.22 | 0.21 | 0.26 | 0.31 | 0.17 | 0.32 | 0.47 | 0.45 | 0.32 | 2.28 | 1.57 | 1.55 | 2.04 | 1.78 | 0.38 | 1.18 | 1.2 | 0.87 | 1.54 | 0.95 | 3.13 | 0.38 | 0.43 | 1.18 | 0.46 | 0.46 | 1.11 | 0.53 | 1.3 | 0.44 | 0.81 | 0.7 | 0.61 | 0.7 | 0.65 | 0.65 | 0.73 | 0.86 | 0.68 | 0.74 | 0.78 | 0.9 | 0.69 | 0.7 | 0.74 | 0.86 | 0.7 | 0.74 | |
| diluted | -0.11 | 0.14 | 0.22 | 0.21 | 0.26 | 0.31 | 0.17 | 0.31 | 0.46 | 0.43 | 0.31 | 2.21 | 1.51 | 1.48 | 1.94 | 1.69 | 0.36 | 1.12 | 1.15 | 0.83 | 1.49 | 0.92 | 3.02 | 0.37 | 0.42 | 1.15 | 0.45 | 0.45 | 1.09 | 0.52 | 1.29 | 0.43 | 0.81 | 0.69 | 0.61 | 0.7 | 0.65 | 0.64 | 0.73 | 0.85 | 0.68 | 0.74 | 0.77 | 0.9 | 0.69 | 0.7 | 0.74 | 0.86 | 0.7 | 0.74 | |
| foreign currency translation adjustments | -11,602,000 | 4,996,000 | 3,282,000 | 17,370,000 | -21,457,000 | -22,668,000 | -2,851,000 | 1,924,000 | -8,646,000 | 5,251,000 | -1,142,000 | 16,928,000 | 11,914,000 | 5,175,000 | -19,403,000 | 11,867,000 | -7,602,000 | -8,464,000 | -1,136,000 | -12,359,000 | 2,297,000 | 1,524,000 | -3,234,000 | 7,128,000 | -7,514,000 | -12,896,000 | 8,521,000 | -20,094,000 | -9,103,000 | 3,840,000 | 733,000 | 3,344,000 | 7,902,000 | 694,000 | -9,264,000 | 1,107,000 | 3,925,000 | ||||||||||||||
| derivative instruments - cash flow hedges | 1,372,500 | 1,288,000 | 2,059,000 | 2,143,000 | -1,199,500 | -5,702,000 | 1,408,000 | ||||||||||||||||||||||||||||||||||||||||||||
| unrealized gains on derivative instruments - cash flow hedges, net of tax of 154 in fy20 | -504,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| income tax benefit | 2,404,250 | 5,223,000 | 4,211,000 | -3,691,750 | 5,244,000 | -27,116,000 | |||||||||||||||||||||||||||||||||||||||||||||
| foreign currency translation gain | -1,092,000 | 5,232,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| unrealized gain on derivative instruments - cash flow hedges | -1,442,250 | -1,854,000 | -3,915,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| unrealized gain on available-for-sale investments | |||||||||||||||||||||||||||||||||||||||||||||||||||
| cash dividends per common share: | 0.24 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.31 | 0.32 | 0.31 | 0.31 | 0.3 | 0.3 | 0.3 | 0.3 | 0.28 | 0.28 | 0.28 | 0.28 | 0.27 | |||||||||||||||||||||||||
| unrealized gains and losses on available-for-sale investments | |||||||||||||||||||||||||||||||||||||||||||||||||||
| unrealized gain on available-for-sale investments, net of tax of (10,120), 293, (4,745), and (1,767), respectively | 5,571,500 | 38,659,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| unrealized gain on available-for-sale investments, net of tax of 799, (1,889), 5,375, and (2,060), respectively | -8,582,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| unrealized gains and losses on available-for-sale investments, net of tax of (171) and 3,752, respectively | 9,714,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| unrealized gain on available-for-sale investments, net of tax of (3,611), 1,644, (3,917) and 2,070, respectively | -32,081,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| unrealized gain on available-for-sale investments, net of tax of 3,466, 526, (306) and 426, respectively | 9,602,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| unrealized losses on available-for-sale investments, net of tax of (3,752) and (100), respectively | -10,125,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| other comprehensive loss | -23,021,000 | -17,591,000 | -28,874,000 | -1,891,000 | -9,634,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| unrealized gain on available-for-sale investments, net of tax of 1,644, 42, 2,070 and (16,887), respectively | 2,200,000 | 2,949,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| unrealized losses on available-for-sale investments, net of tax of (100) and (17,396), respectively | -8,488,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| other income: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| interest income | 1,043,000 | 529,000 | 545,000 | 567,000 | 670,000 | 638,000 | 677,000 | 661,000 | 643,000 | 470,000 | 798,000 | 728,000 | |||||||||||||||||||||||||||||||||||||||
| other non-operating expense | -438,000 | -229,000 | -71,000 | -304,000 | 278,000 | -118,000 | -135,000 | -478,000 | -1,244,000 | -373,000 | -607,000 | -1,175,000 | |||||||||||||||||||||||||||||||||||||||
| total other income | 605,000 | 300,000 | 474,000 | 263,000 | 948,000 | 520,000 | 542,000 | 183,000 | -601,000 | -3,157,000 | 191,000 | -447,000 | |||||||||||||||||||||||||||||||||||||||
| unrealized gains on available-for-sale investments, net of tax of 42, 6,610, (16,887) and (2,659), respectively | -7,610,250 | 5,311,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| unrealized gains on available-for-sale investments, net of tax of 467, (1,680), (16,929) and (9,269), respectively | 1,024,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| unrealized losses on available-for-sale investments, net of tax of (17,396) and (7,589), respectively | -36,776,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| impairment losses on investments | 0 | -3,254,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| unrealized gains on available-for-sale investments, net of tax of 6,610, 13,326, (2,659) and 13,319, respectively | -1,176,500 | 11,851,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| unrealized gains on available-for-sale investments, net of tax of (1,680), 11, (9,269) and , respectively | -2,998,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| unrealized gains on available-for-sale investments, net of tax of (7,589) and (18), respectively | -13,559,000 |
We provide you with 20 years income statements for Bio-Techne stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Bio-Techne stock. Explore the full financial landscape of Bio-Techne stock with our expertly curated income statements.
The information provided in this report about Bio-Techne stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.